CompoAtlas

ToniLymphe Jambes légères

Food supplement declared in France, declaration No 2021-7-484

ToniLymphe Jambes légères is a food supplement declared in France. Status: withdrawn from the market on 31 October 2025. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
BOUCHARA-RECORDATI
Status
Withdrawn from the market on 31 October 2025
Form
Capsule
Daily dose
2 gélules/Jour
Directions for use
2 Gélules par jour au cours des repas, de préférence le matin avec un verre d'eau
Not recommended (according to the manufacturer)
Children (under 12), Pregnant women, Taking anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Blood and lymphatic circulation

Declaration 264334, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Aesculus hippocastanum L.GraineExtrait sec hydroalcoolique120 mg
Vitis vinifera L.FeuilleExtrait sec aqueux90 mg
Ruscus aculeatus L.RacineExtrait sec hydroalcoolique40 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg
Succinate acide de D-alpha-tocophéryleVitamine E300 mg30 mg

Additives

E470b, E464

Other ingredients

Bambusa bambos (L.) Voss, amidon de maïs, maltodextrine

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Ce produit n'est pas destiné aux enfants de moins de 12 ans. L'emploi chez les personnes sous traitement anticoagulant est déconseillé. L'emploi chez les femmes enceintes est déconseillé. Avant toute supplémentation, les femmes allaitantes devront prendre l'avis d'un professionnel de santé

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Aesculus hippocastanum L.
    Read the warning, when it applies and the studies cited

    Horse Chestnut - Aesculus Hippocastanum

    Route of administration: Oral (Bradley 2006; ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Known adverse reactions

    When using this product you may experience headache, dizziness, gastric irritation, or itchiness (Bradley 2006; Mills and Bone 2005; ESCOP 2003).

    Sources cited by Health Canada (3)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Health Canada monograph dated 27 February 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line